1029 related articles for article (PubMed ID: 30016571)
1. Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy.
Duan X; Chan C; Lin W
Angew Chem Int Ed Engl; 2019 Jan; 58(3):670-680. PubMed ID: 30016571
[TBL] [Abstract][Full Text] [Related]
2. Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy.
Gao J; Wang WQ; Pei Q; Lord MS; Yu HJ
Acta Pharmacol Sin; 2020 Jul; 41(7):986-994. PubMed ID: 32317755
[TBL] [Abstract][Full Text] [Related]
3. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
[TBL] [Abstract][Full Text] [Related]
4. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy.
Demuynck R; Engelen Y; Skirtach AG; De Smedt SC; Lentacker I; Krysko DV
Trends Cancer; 2024 Jun; 10(6):486-489. PubMed ID: 38553361
[TBL] [Abstract][Full Text] [Related]
6. Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better.
Thiruppathi J; Vijayan V; Park IK; Lee SE; Rhee JH
Front Immunol; 2024; 15():1375767. PubMed ID: 38646546
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy.
Ji B; Wei M; Yang B
Theranostics; 2022; 12(1):434-458. PubMed ID: 34987658
[TBL] [Abstract][Full Text] [Related]
8. Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death.
Jin F; Liu D; Xu X; Ji J; Du Y
Int J Nanomedicine; 2021; 16():4693-4712. PubMed ID: 34267518
[TBL] [Abstract][Full Text] [Related]
9. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
Qi J; Jin F; Xu X; Du Y
Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
[TBL] [Abstract][Full Text] [Related]
10. Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal.
Wang Z; Chen L; Ma Y; Li X; Hu A; Wang H; Wang W; Li X; Tian B; Dong J
J Nanobiotechnology; 2021 Aug; 19(1):243. PubMed ID: 34384429
[TBL] [Abstract][Full Text] [Related]
11. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
13. Multi-functional nanomedicines for combinational cancer immunotherapy that transform cold tumors to hot tumors.
Cho H; Kim K
Expert Opin Drug Deliv; 2024 Apr; 21(4):627-638. PubMed ID: 38682272
[TBL] [Abstract][Full Text] [Related]
14. An ultrasound-activated nanoplatform remodels tumor microenvironment through diverse cell death induction for improved immunotherapy.
Ma J; Yuan H; Zhang J; Sun X; Yi L; Li W; Li Z; Fu C; Zheng L; Xu X; Wang X; Wang F; Yin D; Yuan J; Xu C; Li Z; Peng X; Wang J
J Control Release; 2024 Jun; 370():501-515. PubMed ID: 38703950
[TBL] [Abstract][Full Text] [Related]
15. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy.
Zhang S; Wang J; Kong Z; Sun X; He Z; Sun B; Luo C; Sun J
Biomaterials; 2022 Mar; 282():121433. PubMed ID: 35202933
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-targeted polyprodrug nanoparticles induce mitochondrial stress for immunogenic chemo-photodynamic therapy of ovarian cancer.
Zhang W; Chen G; Chen Z; Yang X; Zhang B; Wang S; Li Z; Yang Y; Wu Y; Liu Z; Yu Z
J Control Release; 2024 Jul; 371():470-483. PubMed ID: 38849094
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-mediated immunogenic cell death for cancer immunotherapy.
Qi H; Li Y; Geng Y; Wan X; Cai X
Int J Pharm; 2024 May; 656():124045. PubMed ID: 38561134
[TBL] [Abstract][Full Text] [Related]
18. Immunogenic cell death in cancer therapy: Present and emerging inducers.
Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
[TBL] [Abstract][Full Text] [Related]
19. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
20. Activating Nanomedicines with Electromagnetic Energy for Deep-Tissue Induction of Immunogenic Cell Death in Cancer Immunotherapy.
Wang F; Pu K; Li J
Small Methods; 2023 May; 7(5):e2201083. PubMed ID: 36316270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]